Erschienen in:
01.07.2011 | Melanomas
Standardizing Regional Therapy: Developing a Consensus on Optimal Utilization of Regional Chemotherapy Treatments in Melanoma
verfasst von:
Georgia M. Beasley, MD, Douglas S. Tyler, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 7/2011
Einloggen, um Zugang zu erhalten
Excerpt
In this issue of
Annals of Surgical Oncology, Huismans et al. describe their extensive experience with isolated limb infusion (ILI) in the treatment of 185 patients with in-transit melanoma over a 15-year period (1992–2007).
1 The group initially described and introduced the technique of ILI in the early 1990s as a minimally invasive alternative to hyperthermic isolated limb perfusion (HILP) whereby placement of percutaneously placed catheters allows delivery of regional chemotherapy (usually melphalan plus dactinomycin) to an isolated limb.
2 Because of the safety and efficacy of the treatment as well as disappointing results of a multicenter HILP trial, ILI is now utilized at several major U.S. centers and has been demonstrated to be a well-tolerated treatment alternative for patients with advanced extremity melanoma.
3‐
7 …